Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface anionic components refer to a heterogeneous group of negatively charged molecules located on the plasma membrane of host cells and pathogens. These components primarily include glycosaminoglycans (GAGs) such as heparan sulfate proteoglycans (HSPGs), sialic acids, and anionic phospholipids like phosphatidylserine (Campione et al., 2021; Valenti & Antonini, 2005). In the context of pharmacology, these molecules serve as critical attachment factors for various viruses, including SARS-CoV-2, HIV, and HCV, as well as numerous bacterial species, facilitating their initial docking and subsequent entry into host cells (Hu et al., 2021). Therapeutic strategies targeting these components often involve cationic proteins or peptides, such as lactoferrin and antimicrobial peptides (AMPs), which bind to the anionic sites through electrostatic interactions to competitively inhibit pathogen adhesion or disrupt membrane integrity (Berlutti et al., 2011). Additionally, the exposure of certain anionic components like phosphatidylserine on the outer leaflet of cancer cells—a phenomenon typically absent in healthy cells—provides a selective target for anticancer therapies and imaging agents. This broad target class is essential for maintaining membrane potential and mediating cell-cell and cell-matrix interactions, though its non-specific nature presents challenges in achieving high therapeutic selectivity.
Competitive inhibition of pathogen attachment; membrane disruption; opsonization of apoptotic or malignant cells
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface anionic components.